Actylis And Novo Nordisk Pharmatech Have Agreed To Distribute Pharmaceutical Grade Benzalkonium Chloride To The Pharmaceutical And Medical Device Markets In Germany, Spain, Portugal, The UK And Ireland
Portfolio Pulse from Benzinga Newsdesk
Actylis and Novo Nordisk Pharmatech have entered into an agreement to distribute pharmaceutical grade Benzalkonium Chloride in Germany, Spain, Portugal, the UK, and Ireland. This collaboration aims to supply the pharmaceutical and medical device markets in these regions.
March 25, 2024 | 11:40 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Novo Nordisk Pharmatech's partnership with Actylis to distribute Benzalkonium Chloride in several European countries could enhance its market presence and potentially increase its revenue streams.
The partnership with Actylis allows Novo Nordisk Pharmatech to expand its distribution network and access new markets in Europe, which could lead to increased sales and market penetration for its pharmaceutical grade Benzalkonium Chloride.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80